Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Immunotherapeutic vaccine for CML reported in patent literature

Jan. 17, 1997

Roche/Genentech marketing agreement for Roferon-A

Jan. 15, 1997

Aronex out-licenses antibody-toxin complex

Jan. 15, 1997

Treatment begun in pivotal trial of Coulter radioimmunopharmaceutical

Dec. 24, 1996

Positive clinical results reported for MDX-22 in AML patients

Dec. 12, 1996

Positive IDEC-C2B8 phase III trial results announced

Dec. 11, 1996

Medarex bispecific antibody enters phase II in colon cancer patients

Dec. 9, 1996

Sandoz claims MAbs against Lewis group antigens for therapeutic use

Nov. 25, 1996

IDEC to present final pivotal data on IDEC-C2B8

Nov. 22, 1996

NCI sponsors clinical trials with Therion's prostate cancer vaccine

Nov. 22, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...